CANOC

The Canadian Observational Cohort Collaboration (CANOC) is an initiative of the Epidemiology and Population Health Program at the BC-CfE.  It is an integrated network of all registered treatment information from twelve cohort databases across British Columbia, Saskatchewan, Ontario, Quebec and Newfoundland. This collaboration of national researchers and select databases establishes policy-relevant studies in HIV therapeutics, population, and public health. CANOC is funded by the Canadian Institutes of Health Research (CIHR) and the CIHR Canadian Trials Network (CTN).

The primary aims of CANOC are:

  • To develop a nationally and internationally recognized and policy relevant program of research in HIV therapeutics and population and public health in Canada.
  • To establish mentoring, training, and research opportunities for graduate students, post-doctoral fellows, and clinicians interested in HIV cohort research in Canada.
  • To improve research and dissemination to physicians and individuals living with HIV and to improve knowledge translation of research regarding HIV therapeutics into provincial, national, and international HIV treatment guidelines
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below